Storhaug, K.Ø.; Skutlaberg, D.H.; Hansen, B.A.; Reikvam, H.; Wendelbo, Ø.
Carbapenem-Resistant Enterobacteriaceae—Implications for Treating Acute Leukemias, a Subgroup of Hematological Malignancies. Antibiotics 2021, 10, 322.
https://doi.org/10.3390/antibiotics10030322
AMA Style
Storhaug KØ, Skutlaberg DH, Hansen BA, Reikvam H, Wendelbo Ø.
Carbapenem-Resistant Enterobacteriaceae—Implications for Treating Acute Leukemias, a Subgroup of Hematological Malignancies. Antibiotics. 2021; 10(3):322.
https://doi.org/10.3390/antibiotics10030322
Chicago/Turabian Style
Storhaug, Kristin Ølfarnes, Dag Harald Skutlaberg, Bent Are Hansen, Håkon Reikvam, and Øystein Wendelbo.
2021. "Carbapenem-Resistant Enterobacteriaceae—Implications for Treating Acute Leukemias, a Subgroup of Hematological Malignancies" Antibiotics 10, no. 3: 322.
https://doi.org/10.3390/antibiotics10030322
APA Style
Storhaug, K. Ø., Skutlaberg, D. H., Hansen, B. A., Reikvam, H., & Wendelbo, Ø.
(2021). Carbapenem-Resistant Enterobacteriaceae—Implications for Treating Acute Leukemias, a Subgroup of Hematological Malignancies. Antibiotics, 10(3), 322.
https://doi.org/10.3390/antibiotics10030322